Basiliximab
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00074 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 62 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | plasma cell myeloma | KG + DL |
| 2 | bronchitis | KG + DL |
| 3 | indolent plasma cell myeloma | KG + DL |
| 4 | hemoglobinopathy | KG + DL |
| 5 | gastric carcinoma | KG + DL |
| 6 | diffuse gastric adenocarcinoma | KG + DL |
| 7 | partial deletion of the short arm of chromosome 16 | KG + DL |
| 8 | beta-thalassemia with other manifestations | KG + DL |
| 9 | hemolytic anemia due to glucophosphate isomerase deficiency | KG + DL |
| 10 | Jeune syndrome situs inversus | KG + DL |
| 11 | orofacial clefting syndrome | KG + DL |
| 12 | gastric linitis plastica | KG + DL |
| 13 | interventricular septum aneurysm | KG + DL |
| 14 | pyruvate kinase deficiency of red cells | KG + DL |
| 15 | Pierre Robin syndrome associated with a chromosomal anomaly | KG + DL |
| 16 | pulmonary valve disease | KG + DL |
| 17 | partial deletion of the long arm of chromosome 7 | KG + DL |
| 18 | disorder of fucoglycosan synthesis | KG + DL |
| 19 | partial deletion of the long arm of chromosome 22 | KG + DL |
| 20 | genetic syndromic Pierre Robin syndrome | KG + DL |
| 21 | Laubry-Pezzi syndrome | KG + DL |
| 22 | heart disease | KG + DL |
| 23 | severe nonproliferative diabetic retinopathy | KG + DL |
| 24 | gastric adenocarcinoma and proximal polyposis of the stomach | KG + DL |
| 25 | pyropoikilocytosis, hereditary | KG + DL |
| 26 | Epstein-Barr virus-associated carcinoma | KG + DL |
| 27 | gastric cardia adenocarcinoma | KG + DL |
| 28 | carcinoma in situ of gastric cardia | KG + DL |
| 29 | carcinoma in situ of gastric body | KG + DL |
| 30 | diabetic retinopathy | KG + DL |
| 31 | gastric tubular adenocarcinoma | KG + DL |
| 32 | microinvasive gastric cancer | KG + DL |
| 33 | signet ring cell gastric adenocarcinoma | KG + DL |
| 34 | mitral valve disease | KG + DL |
| 35 | bronchial neoplasm (disease) | KG + DL |
| 36 | malignant gastric germ cell tumor | KG + DL |
| 37 | malignant gastric granular cell tumor | KG + DL |
| 38 | cardia cancer | KG + DL |
| 39 | gastric lymphoma | KG + DL |
| 40 | pylorus cancer | KG + DL |
| 41 | gastric cancer | KG + DL |
| 42 | malignant tumor of meninges | KG + DL |
| 43 | gastric neoplasm | KG + DL |
| 44 | spinal cord cancer | KG + DL |
| 45 | laryngotracheitis | KG + DL |
| 46 | cerebral sarcoma | KG + DL |
| 47 | cerebellopontine angle embryonal tumor | KG + DL |
| 48 | childhood brain germinoma | KG + DL |
| 49 | severe early-onset pulmonary alveolar proteinosis due to MARS deficiency | KG + DL |
| 50 | acrocephalopolydactyly | KG + DL |
(Showing top 50 of 62 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.